BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
LOADING
|||
Switch Symbol:
Debt to Assets Over Time
Above historical average, strong compound growth.
Left:
||||
Debt-to-assets ratio
Latest
1.72
↑ 100% above average
Average (9y)
0.86
Historical baseline
Range
High:1.72
Low:0.26
CAGR
+23.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 1.72 | +7.5% |
| 2023 | 1.60 | +18.4% |
| 2022 | 1.35 | +33.7% |
| 2021 | 1.01 | +20.8% |
| 2020 | 0.84 | +72.9% |
| 2019 | 0.48 | +14.7% |
| 2018 | 0.42 | +37.1% |
| 2017 | 0.31 | -48.7% |
| 2016 | 0.60 | +130.0% |
| 2015 | 0.26 | - |